To include your compound in the COVID-19 Resource Center, submit it here.

Merck gains rights to Enbrel biosimilar

Hanwha Chemical Corp. (KSE:09830) partnered with Merck & Co. Inc. (NYSE:MRK) to develop

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE